Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Corticotropin-releasing Hormone (CRH) ELISA Kit-Sandwich

Cat. No.EK8F70

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Canine Corticotropin-releasing Hormone (CRH) ELISA Kit-Sandwich is designed for the quantitative determination of Canine CRH in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Canine CRH.
Target Species Canine
Species Reactivity Canine
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 90 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Corticotropin-releasing hormone (CRH), a hypothalamic hormone, triggers the production and release of ACTH in the anterior pituitary gland and was initially isolated from sheep. The CRH test is considered a quick and dependable method for distinguishing between pituitary-dependent hyperadrenocorticism and cortisol-producing adrenal tumors in dogs.

Target/Biomarker Canine CRH
Target Synonym Corticotropin-releasing Hormone; CRH

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Tanaka, Sachiyo, et al. "Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from cortisol-producing adrenal tumors in dogs." Journal of Veterinary Internal Medicine 36.1 (2022): 29-38.
Inquiry Basket